ID

45483

Descrição

Principal Investigator: Harold I. Feldman, MD, MSCE, University of Pennsylvania, Philadelphia, PA, USA MeSH: Chronic Renal Insufficiency https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000524 The Chronic Renal Insufficiency Cohort (CRIC study) was established in 2001 by the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) to improve the understanding of the relationship between chronic kidney disease and cardiovascular disease. The goals of the CRIC Study are to examine risk factors for progression of chronic kidney disease and cardiovascular disease among patients with chronic kidney disease and to develop predictive models to identify high-risk subgroups, informing future treatment trials and increasing application of available preventive therapies.

Link

dbGap study = phs000524

Palavras-chave

  1. 31/10/2022 31/10/2022 - Simon Heim
  2. 13/12/2022 13/12/2022 - Kristina Keller
Titular dos direitos

Harold I. Feldman, MD, MSCE, University of Pennsylvania, Philadelphia, PA, USA

Transferido a

13 de dezembro de 2022

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

dbGaP phs000524 Chronic Renal Insufficiency Cohort Study (CRIC)

Eligibility Criteria

  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. This data table contains subject IDs and consent group information for subjects with chronic renal insufficiency.
    3. The data table contains mapping of study subject IDs to sample IDs for subjects with chronic renal insufficiency. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. Also included is the sample use.
    4. The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
    5. The sample attributes data table includes sample analyte type (DNA or RNA), body site where samples were collected, is tumor status, and histological type.
Inclusion and exclusion criteria
Descrição

Inclusion and exclusion criteria

Participants are no longer being enrolled in the study. The following Inclusion/Exclusion Criteria were followed at the time of participant recruitment.
Descrição

Participants are no longer being enrolled in the study. The following Inclusion/Exclusion Criteria were followed at the time of participant recruitment.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
Inclusion: 21 to 74 years; Age Based eGFR: 21-44 years 20-70 ml/min/1/73m2), 45-64 years 20-60 ml/min/1/73m2, 65-74 years 20-50 ml/min/1/73m2.
Descrição

Inclusion: 21 to 74 years; Age Based eGFR: 21-44 years 20-70 ml/min/1/73m2), 45-64 years 20-60 ml/min/1/73m2, 65-74 years 20-50 ml/min/1/73m2.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0001779
UMLS CUI [1,3]
C0017654
Exclusion: Institutionalized, unable or unwilling to provide informed consent, participant appears unlikely or unable to participate in the required study procedures as assessed by the investigator, study coordinator or designee, NYHA Class III or IV heart failure at baseline, known cirrhosis based on patient self-report, known HIV infection and/or AIDS based on patient self-report, present participation in the AASK Cohort Study, pregnant women.
Descrição

Exclusion: Institutionalized, unable or unwilling to provide informed consent, participant appears unlikely or unable to participate in the required study procedures as assessed by the investigator, study coordinator or designee, NYHA Class III or IV heart failure at baseline, known cirrhosis based on patient self-report, known HIV infection and/or AIDS based on patient self-report, present participation in the AASK Cohort Study, pregnant women.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C1299582
UMLS CUI [1,4]
C0558080
UMLS CUI [2,1]
C2828389
UMLS CUI [2,2]
C1299582
UMLS CUI [2,3]
C0558080
UMLS CUI [2,4]
C0679823
UMLS CUI [2,5]
C0947630
UMLS CUI [3,1]
C2828389
UMLS CUI [3,2]
C1536132
UMLS CUI [3,3]
C1536133
UMLS CUI [4,1]
C2828389
UMLS CUI [4,2]
C1623038
UMLS CUI [4,3]
C0681906
UMLS CUI [4,4]
C3829825
UMLS CUI [5,1]
C2828389
UMLS CUI [5,2]
C0033011
UMLS CUI [6,1]
C2828389
UMLS CUI [6,2]
C0030699
UMLS CUI [6,3]
C0009247

Similar models

Eligibility Criteria

  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. This data table contains subject IDs and consent group information for subjects with chronic renal insufficiency.
    3. The data table contains mapping of study subject IDs to sample IDs for subjects with chronic renal insufficiency. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. Also included is the sample use.
    4. The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
    5. The sample attributes data table includes sample analyte type (DNA or RNA), body site where samples were collected, is tumor status, and histological type.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Inclusion and exclusion criteria
Participants are no longer being enrolled in the study. The following Inclusion/Exclusion Criteria were followed at the time of participant recruitment.
Item
Participants are no longer being enrolled in the study. The following Inclusion/Exclusion Criteria were followed at the time of participant recruitment.
boolean
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Inclusion: 21 to 74 years; Age Based eGFR: 21-44 years 20-70 ml/min/1/73m2), 45-64 years 20-60 ml/min/1/73m2, 65-74 years 20-50 ml/min/1/73m2.
Item
Inclusion: 21 to 74 years; Age Based eGFR: 21-44 years 20-70 ml/min/1/73m2), 45-64 years 20-60 ml/min/1/73m2, 65-74 years 20-50 ml/min/1/73m2.
boolean
C1512693 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
C0017654 (UMLS CUI [1,3])
Exclusion: Institutionalized, unable or unwilling to provide informed consent, participant appears unlikely or unable to participate in the required study procedures as assessed by the investigator, study coordinator or designee, NYHA Class III or IV heart failure at baseline, known cirrhosis based on patient self-report, known HIV infection and/or AIDS based on patient self-report, present participation in the AASK Cohort Study, pregnant women.
Item
Exclusion: Institutionalized, unable or unwilling to provide informed consent, participant appears unlikely or unable to participate in the required study procedures as assessed by the investigator, study coordinator or designee, NYHA Class III or IV heart failure at baseline, known cirrhosis based on patient self-report, known HIV infection and/or AIDS based on patient self-report, present participation in the AASK Cohort Study, pregnant women.
boolean
C2828389 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0558080 (UMLS CUI [1,4])
C2828389 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
C0679823 (UMLS CUI [2,4])
C0947630 (UMLS CUI [2,5])
C2828389 (UMLS CUI [3,1])
C1536132 (UMLS CUI [3,2])
C1536133 (UMLS CUI [3,3])
C2828389 (UMLS CUI [4,1])
C1623038 (UMLS CUI [4,2])
C0681906 (UMLS CUI [4,3])
C3829825 (UMLS CUI [4,4])
C2828389 (UMLS CUI [5,1])
C0033011 (UMLS CUI [5,2])
C2828389 (UMLS CUI [6,1])
C0030699 (UMLS CUI [6,2])
C0009247 (UMLS CUI [6,3])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial